Literature DB >> 9648935

The actions of exogenous dehydroepiandrosterone in experimental animals and humans.

F Svec1, J R Porter.   

Abstract

Dehydroepiandrosterone (DHEA) is the major adrenal steroid of young adults; however, its physiologic functions, if any, are not known. The purpose of this review is to evaluate the current literature in which DHEA was administered to either humans or experimental animals to discern what these functions might be. Reports are divided into five areas: neurologic, immunologic, cardiovascular, oncologic, and metabolic. Particular attention is paid to the dosage and route of administration. This type of analysis shows that at the lowest doses, DHEA has effects on neurologic and immunologic tissues, suggesting that these two sites may be physiologic targets. DHEA also affects cardiologic and metabolic functions as well as tumor growth, but such actions require higher doses and may reflect 'pharmacologic' activities. It is proposed that DHEA's pattern of activity represents a new class of steroid hormones, the "Regnantoids." Further progress in the endocrinology of this family of steroids may only come when synthetic, long-acting analogs of DHEA are available for in vitro studies to allow correlations between hormone action and receptor binding.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9648935     DOI: 10.3181/00379727-218-44285

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


  21 in total

1.  Opposing actions of adrenal androgens and glucocorticoids on alternative splicing of Slo potassium channels in bovine chromaffin cells.

Authors:  Guey-Jen Lai; David P McCobb
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

2.  HE3286 reduces axonal loss and preserves retinal ganglion cell function in experimental optic neuritis.

Authors:  Reas S Khan; Kimberly Dine; Esteban Luna; Clarence Ahlem; Kenneth S Shindler
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-08-19       Impact factor: 4.799

3.  16alpha-bromoepiandrosterone, an antimalarial analogue of the hormone dehydroepiandrosterone, enhances phagocytosis of ring stage parasitized erythrocytes: a novel mechanism for antimalarial activity.

Authors:  Kodjo Ayi; Giuliana Giribaldi; Aleksei Skorokhod; Evelin Schwarzer; Patrick T Prendergast; Paolo Arese
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

4.  DHEA-dependent and organ-specific regulation of TNF-alpha mRNA expression in a murine polymicrobial sepsis and trauma model.

Authors:  Tanja Barkhausen; Frank Hildebrand; Christian Krettek; Martijn van Griensven
Journal:  Crit Care       Date:  2009-07-13       Impact factor: 9.097

5.  HE3286, an oral synthetic steroid, treats lung inflammation in mice without immune suppression.

Authors:  Douglas Conrad; Angela Wang; Raymond Pieters; Ferdinando Nicoletti; Katia Mangano; Anna M van Heeckeren; Steven K White; James M Frincke; Christopher L Reading; Dwight Stickney; Dominick L Auci
Journal:  J Inflamm (Lond)       Date:  2010-10-30       Impact factor: 4.981

6.  Metabolic and cardiovascular profile in patients with Addison's disease under conventional glucocorticoid replacement.

Authors:  R Giordano; S Marzotti; M Balbo; S Romagnoli; E Marinazzo; R Berardelli; G Migliaretti; A Benso; A Falorni; E Ghigo; E Arvat
Journal:  J Endocrinol Invest       Date:  2009-07-20       Impact factor: 4.256

Review 7.  Pharmacology and therapeutic effects of dehydroepiandrosterone in older subjects.

Authors:  Sylvie Legrain; Laurence Girard
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

8.  Dehydroepiandrosterone: a modulator of cellular immunity and heat shock protein 70 production during polymicrobial sepsis.

Authors:  Reiner Oberbeck; Hanno Deckert; Jörg Bangen; Phillip Kobbe; Daniel Schmitz
Journal:  Intensive Care Med       Date:  2007-09-26       Impact factor: 17.440

9.  Dehydroepiandrosterone therapy ameliorates experimental autoimmune myasthenia gravis in Lewis rats.

Authors:  Rui-Sheng Duan; Hans Link; Bao-Guo Xiao
Journal:  J Clin Immunol       Date:  2003-03       Impact factor: 8.317

10.  Dehydroepiandrosterone and metformin regulate proliferation of murine T lymphocytes.

Authors:  M E Solano; V Sander; M R Wald; A B Motta
Journal:  Clin Exp Immunol       Date:  2008-06-28       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.